World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
105
Citations
67815
World Ranking
615
National Ranking
310

Medicine

D-Index
107
Citations
69758
World Ranking
6102
National Ranking
3266

Robert L. Nussbaum publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Robert L. Nussbaum sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 369 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Robert L. Nussbaum D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Robert L. Nussbaum sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 105 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Robert L. Nussbaum is affiliated with the University of California, San Francisco in the United States. Their research primarily spans the fields of biochemistry, genetics, and molecular biology, with significant contributions in medicine. Nussbaum's work has a strong focus on genetics and molecular biology, cardiology and cardiovascular medicine, cancer research, and pulmonary and respiratory medicine.

The scientist's main topics of study include BRCA gene mutations in cancer, genomics and rare diseases, cancer genomics and diagnostics, genetic factors in colorectal cancer, cardiomyopathy and myosin studies, genomic variations and chromosomal abnormalities, and ethics in clinical research.

Nussbaum has published extensively in notable scientific venues. Frequent publication outlets include the Journal of Clinical Oncology, Cancer Research, The American Journal of Human Genetics, Genetics in Medicine, and bioRxiv (Cold Spring Harbor Laboratory).

Among recent research papers, significant works include:

  • Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths (2021, Science Immunology)
  • X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19 (2021, Science Immunology)
  • Comparison of Universal Genetic Testing vs Guideline-Directed Targeted Testing for Patients With Hereditary Cancer Syndrome (2020, JAMA Oncology)
  • The role of exome sequencing in newborn screening for inborn errors of metabolism (2020, Nature Medicine)
  • Yield and Utility of Germline Testing Following Tumor Sequencing in Patients With Cancer (2020, JAMA Network Open)

Frequent co-authors collaborating with Nussbaum include Edward D. Esplin, Sarah M. Nielsen, Kathryn E. Hatchell, Brandie Heald, and Swaroop Aradhya.

Best Publications

  • Mutation in the α-synuclein gene identified in families with Parkinson's disease

    Mihael H. Polymeropoulos;Christian Lavedan;Elisabeth Leroy;Susan E. Ide

  • The International HapMap Project

    John W. Belmont;Paul Hardenbol;Thomas D. Willis;Fuli Yu

  • α-Synuclein Locus Triplication Causes Parkinson's Disease

    A. B. Singleton;M. Farrer;J. Johnson;A. Singleton

  • Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1

    Eriza Maria Valente;Patrick M. Abou-Sleiman;Viviana Caputo;Miratul M K Muqit

  • ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

    Robert C. Green;Robert C. Green;Jonathan S. Berg;Wayne W. Grody;Sarah S. Kalia

  • Alzheimer's Disease and Parkinson's Disease

    Robert L. Nussbaum;Christopher E. Ellis

  • Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein

    Deborah E. Cabin;Kazuhiro Shimazu;Diane Murphy;Nelson B. Cole

  • ClinGen — The Clinical Genome Resource

    Heidi L. Rehm;Jonathan S. Berg;Lisa D. Brooks;Carlos D. Bustamante

  • Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23

    Mihael H. Polymeropoulos;Joseph J. Higgins;Lawrence I. Golbe;William G. Johnson

  • Structure and Dynamics of Micelle-bound Human α-Synuclein

    Tobias S. Ulmer;Ad Bax;Nelson B. Cole;Robert L. Nussbaum

  • The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein.

    Haruhiko Siomi;Mikiko C. Siomi;Robert L. Nussbaum;Gideon Dreyfuss

  • Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).

    Nasim Mavaddat;Daniel Barrowdale;Irene L. Andrulis;Susan M. Domchek

  • Direct Membrane Association Drives Mitochondrial Fission by the Parkinson Disease-associated Protein α-Synuclein

    Ken Nakamura;Venu M. Nemani;Farnaz Azarbal;Gaia Skibinski

  • Association Between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer

    Kelly L. Bolton;Kelly L. Bolton;Georgia Chenevix-Trench;Cindy Goh;Siegal Sadetzki

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Lipid droplet binding and oligomerization properties of the Parkinson's disease protein α-synuclein

    Nelson B. Cole;Diane D. Murphy;Theresa Grider;Susan Rueter

  • Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase.

    Lei Bi;Ichiro Okabe;David J. Bernard;Anthony Wynshaw-Boris

  • The Lowe's oculocerebrorenal syndrome gene encodes a protein highly homologous to inositol polyphosphate-5-phosphatase.

    Attree O;Olivos Im;Okabe I;Bailey Lc

  • Essential role for KH domains in RNA binding: impaired RNA binding by a mutation in the KH domain of FMR1 that causes fragile X syndrome.

    Haruhiko Siomi;Mleyoung Choi;Mikiko C. Siomi;Robert L. Nussbaum

  • Genetic/familial high-risk assessment: breast and ovarian.

    Mary B. Daly;Jennifer E. Axilbund;Saundra Buys;Beth Crawford

Frequent Co-Authors

Irene L. Andrulis
Irene L. Andrulis University of Toronto
Roderick R. McInnes
Roderick R. McInnes University of Toronto
Eitan Friedman
Eitan Friedman City University of New York
Georgia Chenevix-Trench
Georgia Chenevix-Trench QIMR Berghofer Medical Research Institute
Antonis C. Antoniou
Antonis C. Antoniou University of Cambridge
Javier Benitez
Javier Benitez Instituto de Salud Carlos III
Judy Garber
Judy Garber Harvard University
Douglas F. Easton
Douglas F. Easton University of Cambridge
Kenneth Offit
Kenneth Offit Memorial Sloan Kettering Cancer Center
Marco Montagna
Marco Montagna Istituto Oncologico Veneto

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA opens a wealth of opportunities in healthcare and allied fields. If you're interested in supporting patient care but prefer alternative options, several online degrees can offer rewarding career pathways.

For those who enjoy working with medical records, pursuing medical coding certification offers a route into the healthcare industry without direct patient interaction. These programs are often affordable and can be completed online at your own pace.

If your goal is patient care, easy to get into nursing programs can help you begin a fulfilling nursing career. Many options exist for online coursework combined with local clinical placements.

Interested in using your skills to lead teams or manage health services? Consider an accelerated healthcare administration degree online for a rapid pathway to leadership roles. Alternatively, a healthcare administration degree offers flexibility and affordability for advancing your career.

Combining a foundation in genetics with these related degrees can broaden your career prospects and help you make meaningful contributions in the ever-evolving healthcare sector.

Best Scientists Citing Robert L. Nussbaum

Trending Scientists